The concept of “doing no significant harm” runs through the EU Horizon Europe project BlueRemediomics, and has been explored in the past in “Town Hall”
In time for the Sixteenth meeting of the Conference of the Parties to the Convention on Biological Diversity (COP 16) taking place from the 21st of October
BlueRemediomics researcher Professor Marcel Jaspars from the University of Aberdeen has co-authored a new article published by Nature Communications on “Harmonizing rules for digital sequence
Extensive expedition provides new insights into the human impact on the ocean biome with land and sea samples The completion of the 15-month-long Traversing European
BlueRemediomics project co-coordinator Rob Finn from EMBL was recently interviewed for an article in Nature Biotechnology on “Plastic-eating bacteria that boost the growing business of
A hybrid interactive workshop with over 30 people, exploring “human impacts on oceans”, was held on 3 September 2024 in Aberdeen’s Anatomy Rooms by Aberdeen
BlueRemediomics partner EMBL has announced the release of an updated version of the MGnify Genomes marine catalogue. This latest release (v2.0) of the marine catalogue
In time for the upcoming second meeting of the “Working Group on Benefit-sharing from the Use of Digital Sequence Information on Genetic Resources” (WGDSI-2) taking
A new article, co-authored by Professor Marcel Jaspars from the University of Aberdeen, was recently published in the Pharmaceutical Journal giving an overview of why
From the 4th to the 12th of May 2024, the research schooner Tara docked in Naples, Italy, for an important port call as part of